Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.
Charlene M MantiaOpeyemi A JegedeElizabeth R PlimackThomas PowlesRobert J MotzerNizar M TannirChung-Han LeeYoshihiko TomitaMartin H VossToni K ChoueiriBrian I RiniHans J HammersBernard EscudierLaurence AlbigèsLisa RosenblattMichael B AtkinsMeredith M ReganDavid F McDermottPublished in: Journal for immunotherapy of cancer (2024)
NCT02231749.
Keyphrases